These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 29217419)
1. In vitro activity of tedizolid against the Mycobacterium abscessus complex. Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex. Zhang Z; Lu J; Song Y; Pang Y Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186 [TBL] [Abstract][Full Text] [Related]
4. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination. Pryjma M; Burian J; Thompson CJ Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147 [No Abstract] [Full Text] [Related]
5. Le Run E; Arthur M; Mainardi JL Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387 [No Abstract] [Full Text] [Related]
6. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan. Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605 [TBL] [Abstract][Full Text] [Related]
10. Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand. Ananta P; Kham-Ngam I; Chetchotisakd P; Chaimanee P; Reechaipichitkul W; Namwat W; Lulitanond V; Faksri K PLoS One; 2018; 13(11):e0208053. PubMed ID: 30496270 [TBL] [Abstract][Full Text] [Related]
11. Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Pryjma M; Burian J; Kuchinski K; Thompson CJ Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874379 [TBL] [Abstract][Full Text] [Related]
12. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus. Kim TS; Choe JH; Kim YJ; Yang CS; Kwon HJ; Jeong J; Kim G; Park DE; Jo EK; Cho YL; Jang J Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674049 [No Abstract] [Full Text] [Related]
14. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing]. Gui J; Wang F; Hong CY; Li JL; Liang J Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731 [TBL] [Abstract][Full Text] [Related]
15. Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. Myojin S; Fukuoka K; Kanemaru A; Baba S; Okamoto Y; Suzuki H; Kamada K; Yoshida A; Kikuchi K; Horikoshi Y Int J Infect Dis; 2018 Sep; 74():10-12. PubMed ID: 29966711 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830 [TBL] [Abstract][Full Text] [Related]
17. Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the Zheng H; Liu D; Lu J; Song Y; Wang S; Zhao Y; Ni X Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397054 [TBL] [Abstract][Full Text] [Related]
18. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study. Ruedas-López A; Tato M; Broncano-Lavado A; Esteban J; Ruiz-Serrano MJ; Sánchez-Cueto M; Toro C; Domingo D; Cacho J; Barrado L; López-Roa P Microbiol Spectr; 2023 Jun; 11(3):e0504122. PubMed ID: 37212700 [TBL] [Abstract][Full Text] [Related]
19. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease. Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300 [TBL] [Abstract][Full Text] [Related]
20. Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease? Ruth MM; Koeken VACM; Pennings LJ; Svensson EM; Wertheim HFL; Hoefsloot W; van Ingen J J Antimicrob Chemother; 2020 Mar; 75(3):609-617. PubMed ID: 31886864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]